FY

Fatema Yusuf Kachwala

Active Director Additional Director DIN 11510734
DIN 11510734 First appointment Jan 2026 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Fatema Yusuf Kachwala

Data last updated:

Fatema Yusuf Kachwala is an Additional Director at Yashfeen Healthcare Private Limited (since 2026). The company operates in Paper.

DIN 11510734
Primary Designation Additional Director
Industry Paper
First Appointment 01 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yashfeen Healthcare Private Limited U21001MH2023PTC398265
Additional Director01 Jan 2026Active

Board colleagues of Fatema Yusuf Kachwala

NameDINCompanyDesignation
Yusuf Zuzer Kachwala08590869Yashfeen Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yashfeen Healthcare Private Limited
Premium access

Shareholding and investment profile for Fatema Yusuf Kachwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fatema Yusuf Kachwala

Fatema Yusuf Kachwala currently holds 1 directorship: Yashfeen Healthcare Private Limited (Additional Director, since 01 Jan 2026).

Fatema Yusuf Kachwala was first appointed on 01 Jan 2026 as Additional Director at Yashfeen Healthcare Private Limited.

The current boards of Fatema Yusuf Kachwala's companies include Yusuf Zuzer Kachwala (Yashfeen Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available